BASF divests Nutrilife baking enzymes business to Lallemand

Lallemand, through its subsidiary Danstar Ferment, is acquiring German multinational  BASF’s Nutrilife baking enzymes portfolio and business in a deal expected to complete by the end of the month.

Michael de Marco, BASF’s vice-president, global business management enzymes, said: “Baking enzymes is not a strategic fit for BASF. With Lallemand we have found an excellent partner to strategically continue and strengthen our baking enzymes business and to be a reliable supplier. We will accompany the transaction to ensure a smooth handover for our customers.”

Montreal-headquartered Lallemand is a family-owned business focused on the development, production and marketing of yeasts, bacteria, fungi and enzymes-based solutions across the baking, food ingredients, human and animal nutrition and health, crop protection, nutrition, oenology, brewing, alcohol and biofuel sectors. The company is present in more than 50 countries, operates more than 45 production plants and has around 4,500 employees.

Lallemand entered recently into the development and production of enzymes. Lars Asferg, president of Lallemand Bio-Ingredients, said: “We look forward to continuing to provide Nutrilife customers with enzyme expertise as well as access to innovative ingredients based on the Lallemand yeast and bacteria technology platforms.”